Coherent Corp SEC Filings

Coherent Corp. director reports stock option exercise and share sale. A company director filed a Form 4 disclosing that on 11/28/2025 they exercised an option to acquire 1,000 shares of Coherent Corp. common stock at an exercise price of $21.67 per share, then sold 1,000 shares of common stock at a price of $158.36 per share on the same date.

Following these transactions, the director beneficially owned 50,019 shares of Coherent Corp. common stock and 8,240 derivative securities (stock options). The reported option originally vested in four equal annual installments beginning on August 17, 2017.

COHR filed a notice that a holder plans to sell common shares under Rule 144. The planned sale covers 1,377 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $224,051.67 and an approximate sale date of 12/01/2025. These 1,377 shares were acquired as restricted stock from the issuer on 08/28/2024, with payment made the same day. The filing notes that 157,153,611 shares of this class were outstanding, providing context for the size of the proposed sale.

A shareholder of COHR has filed a Form 144 notice to potentially sell 1,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of 158360.00, compared with 157,153,611 shares outstanding, so this is a very small transaction relative to the company’s total equity.

The securities to be sold were acquired on 11/28/2025 by exercising stock options under a registered plan, with the purchase price paid in cash on the same date. Form 144 indicates the filer’s intent to rely on Rule 144 for resales and confirms that the filer represents not knowing any undisclosed material adverse information about the issuer.

Coherent Corp. director reports stock sale

A director of Coherent Corp. (COHR) reported selling 2,831 shares of Coherent common stock on 11/21/2025 at a price of $134.85 per share. After this transaction, the director beneficially owns 21,078 shares of Coherent common stock in direct ownership. The filing is a routine Form 4 disclosure of insider trading activity required by U.S. securities regulations.

BCPE Watson (DE) BML, LP, an affiliate of Bain Capital, updated its ownership report for Coherent Corp. common stock. The reporting person now beneficially owns 14,868,245 shares of common stock, representing 7.9% of the class, primarily through convertible Series B preferred stock. On November 24, 2025, it converted 20,977 shares of Series B-1 and 33,135 shares of Series B-2 preferred into 7,592,307 common shares and sold 7,500,000 common shares in a Rule 144 block trade at $143.37 per share, for total proceeds of $1,075,275,000. The holder plans to distribute 92,307 common shares to its members or partners for charitable gifts for no consideration. A new Conversion Cap Agreement limits its beneficial ownership to 9.99%, and a Waiver Agreement gives up rights to dividends on all Series B preferred stock on or after November 20, 2025.

Coherent (COHR) shareholder BCPE Watson (DE) BML, LP has filed a Form 144 to sell 7,500,000 shares of Coherent common stock through Goldman Sachs & Co. LLC on the NYSE. The shares have an stated aggregate market value of $1,075,275,000 and are part of a class with 157,153,611 shares outstanding. The stock is identified as common stock with no par value, and the approximate sale date listed is November 24, 2025.

The shares to be sold were acquired on November 25, 2025 upon conversion of Series B-1 and Series B-2 Convertible Preferred Stock, which were each settled with cash on March 31, 2021 and July 1, 2022, respectively, for a total of 2,971,280 and 4,528,720 shares. The filing also reports that BCPE Watson (DE) BML, LP sold 7,500,000 Coherent common shares on November 7, 2025 for gross proceeds of $1,075,275,000. The seller represents that it is not aware of any undisclosed material adverse information about Coherent’s current or prospective operations.

Coherent Corp. (COHR) reported an insider stock sale by a director. On 11/20/2025, the reporting person sold 2,000 shares of Coherent common stock at a price of $150 per share, as shown in Table I of the filing. The transaction is coded as an open market or similar sale and was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2024. Following this sale, the reporting person beneficially owns 20,108 shares of Coherent common stock, held directly.

Coherent Corp. insider plans a small Rule 144 stock sale. A holder has filed a notice to sell 2,831 shares of common stock of the issuer through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $381,760.35. The filing states that 157,153,611 shares of common stock were outstanding, providing context for the planned sale.

The shares to be sold were acquired on 08/28/2025 as restricted stock that vested under a registered plan from the issuer in exchange for services rendered, with payment also made on 08/28/2025. The person filing represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Coherent Corp. announced that it has entered into a Waiver Agreement with Bain Capital, the holder of its Series B-1 and Series B-2 Convertible Preferred Stock. Under this agreement, Bain Capital irrevocably and unconditionally waives all rights to receive dividends on any shares of these Series B preferred stocks from the date of the agreement onward, as provided under the existing share terms.

The company notes that Bain Capital, which retains a substantial ownership position in Coherent despite prior sales and charitable distributions, agreed to this waiver as part of a mutually negotiated arrangement. Coherent highlights the waiver as a positive development that it believes strengthens alignment between Bain Capital and common shareholders and reflects support for the company’s strategic priorities.